Blog Voices from the Frontlines

May 082020

The Cost of Non-Compliance - Americans for Safe Access

While most cannabis and hemp businesses understand that they must follow a set of guidelines and implement certain quality control factors into their daily operations, many do not understand the depth of compliance and documentation needed to meet all state and federal requirements. Countless operators complain about the cost of compliance, without factoring in the costs of non-compliance. As enforcement activities increase across states and as the federal government establishes guidelines for hemp and CBD production, it is more important than ever that businesses take the necessary steps to reach and maintain compliance.

May 072020

5 Ways to Thank Essential Workers - Americans for Safe Access

While many of us are stuck inside, safe in our homes, most essential workers are still making their commutes into work every day. Whether they’re preparing the food we eat, saving lives in the ICU, delivering packages, or working in a dispensary to provide medicine to patients; these individuals are putting themselves at risk to ensure that the essential services we rely on remain open.

As a token of appreciation to all those that are putting their lives at risk to help service others, we have created a list of 5 ways you can thank the essential workers in your life.

Apr 272020

Update on Cannabis Rescheduling at the United Nations - Americans for Safe Access

In March 2020, the United Nations Committee on Narcotic Drugs (CND) was expected to vote on the WHO’s recommendations on the scheduling of cannabis and cannabis products during their annual meeting in Vienna, Austria. However, the CND decided to delay the vote until its next meeting in December 2020.  This marks the second time the vote was delayed. 

The CND is responsible for implementing international drug control treaties as well as making decisions about scheduling new substances as well as changing the scheduling of drugs. The CND bases these decisions on recommendations from the World Health Organization (WHO). The WHO makes their recommendations on the scheduling of drugs based on the WHO Expert Committee on Drug Dependence (ECDD) critical review document.

Apr 242020

Medical Cannabis Patient Scores Important Victory in Employment Discrimination Lawsuit against Amazon in New Jersey - Americans for Safe Access

Employment protections for medical cannabis patients in New Jersey could soon be strengthened following an important win for the plaintiff in an employment discrimination lawsuit filed against Amazon last year -- D.J.C. v. Amazon Com DEDC, LLC, et al. The federal court ruling, issued earlier this month, will allow the lawsuit to proceed in state court, paving the way for a more employee-friendly resolution of the case. 

Mar 242020

Cannabinoids, Influenza, and Coronavirus - Americans for Safe Access

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health. Each person’s health situation is unique, and medical cannabis patients should discuss with their doctor or healthcare provider the best approach to prevent and treat current illnesses while potentially battling influenza or coronavirus.

Mar 092020

Office of Medical Cannabis Control: A New Way to End the State/Federal Conflict Regarding Medical Cannabis - Americans for Safe Access

There are now over 3 million medical cannabis patients across the country; ninety-one percent of Americans now live in states with some form of access to medical cannabis, while sixty-six of American adults are in favor of full legalization. Despite this, cannabis retains its Schedule I status under the Controlled Substances Act, meaning the federal government considers it to be a dangerous, highly addictive substance with no medical value. This continues to cause numerous conflicts between the federal government and the states that have rolled out these health programs for their citizens. The only protection for these programs in federal law is the Rohrabacher–Farr amendment found in the Commerce Justice Science and Related Agencies appropriations bill which, as a budget bill, is subject to change each year. Plans for legalization at the federal level by different means have been introduced for years with little impact; H.R.3884, The Marijuana Opportunity Reinvestment and Expungement Act of 2019, was the first and only bill of this nature to clear a Congressional committee. It is time for a new approach to end the federal conflict on cannabis policy.

Feb 282020

Important Update from USDA - Americans for Safe Access

The signing of the Agriculture Improvement Act of 2018 (the 2018 Farm Bill) into law resulted in the descheduling of hemp and opened the door to the wide scale production of the crop. It also tasked the United States Department of Agriculture (USDA) with establishing rules and regulations around hemp cultivation, including adherence to the legal limit of 0.3% THC by dry weight. USDA released its Interim Final Rule on Hemp on October 31, 2019. The team at Americans for Safe Access (along with almost 4,700 hundred other organizations and individuals) submitted comments on the new rule before the public comment period closed on January 29, 2020.

Oct 012019

Patient-Focused Recommendations Regarding the Vaping Crisis - Americans for Safe Access

Update 11/8/2019: The CDC has confirmed that out of 29 samples of lung fluid from affected patients all samples tested positive for Vitamin E acetate. This has led the CDC to consider Vitamin E acetate to be a "chemical of concern."

Over the past two months, the Centers for Disease Control and Prevention (CDC) has been working with state and local departments of health around the country to identify cases of what has come to be known as Vaping-Associated Pulmonary Illness (VAPI). As of 5:00 PM on September 25, the CDC had confirmed 805 cases of lung injury in 46 states and one U.S. territory. The CDC also confirmed a total of 12 deaths in 10 states.


While several states have issued recommendations to quit using vapes, other states have banned, or are currently looking into banning, vaporization products (for both nicotine and cannabis) altogether. Massachusetts has banned the sale of all vaporization products for four months, and New York and Michigan are banning sales of flavored vaping products. Other jurisdictions, such as Los Angeles, are considering bans as well.

Sep 262019

How the Historic Passage of the SAFE Banking Act Could Benefit Patients - Americans for Safe Access

“The potential benefits that patients stand to gain from passage of the SAFE Banking Act are significant. Americans for Safe Access is proud to have supported this historic bill since its introduction and reiterates its call for swift passage in the Senate. Broader, more robust cannabis reform is still urgently needed, but the Act’s passage through the House is an encouraging sign that we are on the right path.”-Sean Khalepari, ASA Regulatory Affairs Coordinator

This week cannabis legislation made history. The first ever federal cannabis reform legislation was passed by the House of Representatives by a vote of 321-103. This bill will still need to pass the Senate and be signed into law, but it serves as a marker of the progress cannabis legislation has made.

Sep 102019

Abridged Guide to State Cannabis Laws - Americans for Safe Access

We are happy to share this brief guide to State Cannabis Laws with you. Created with the talented designers of Centennial Media this guide serves as a bite-sized version of the full analysis of state laws available on our website under: "Legal Information By State & Federal Law."